Tuesday, October 26, 2010
New Diabetes Drug ONGLYZA is Now Available
A newly approved diabetes drug, Onglyza, is now available in U.S. pharmacies, effective Friday August 14, 2009.
Bristol Myers-Squibb and AstraZeneca PLC, which co-developed and will co-market the drug, said that Onglyza was approved as an adjunct to diet and exercise to improve blood-sugar control in adults for the treatment of type 2 diabetes mellitus.
It belongs to a class of drugs known as DPP-4 inhibitors, and will compete directly with the only other such drug on the market, Merck &
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment